NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Angiogenesis



Research from University of Bristol provides new data on angiogenesis



May 20th, 2008

According to recent research from Bristol, the United Kingdom, "Vascular endothelial growth factor-A is widely regarded as the principal stimulator of angiogenesis required for tumour growth. VEGF is generated as multiple isoforms of two families, the pro-angiogenic family generated by proximal splice site selection in the terminal exon, termed VEGF(xxx), and the anti-angiogenic family formed by distal splice site selection in the terminal exon, termed VEGF(xxx)b, where xxx is the amino acid number."

"The most studied isoforms, VEGF(165) and VEGF(165)b have been shown to be present in tumour and normal tissues respectively. VEGF165b has been shown to inhibit VEGF- and...


Source: Cancer Weekly (2008-05-20)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login